US Patent 11034771 Anti-CD73 anti-PD-L1 bispecific antibodies
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+177 characters)
Article
Patent abstract
Provided are bispecific antibodies capable of binding to human CD73 protein and human PD-L1 protein. These bispecific antibodies are effective in treating cancer.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Bingshi Guo0
Jingwu Zang0
Lei Fang0
Qiumei Yang0
Zhengyi Wang0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 31 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 27 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
110347710
Date of Patent
June 15, 2021
0Patent Application Number
169630910
Date Filed
July 25, 2019
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 11034771 Anti-CD73 anti-PD-L1 bispecific antibodies
Infobox
Is a
Patent jurisdiction
Patent number
11034771
Date of patent
June 15, 2021
Patent application number
16963091
Date Filed
July 25, 2019
Patent citations
Patent primary examiner
Find more entities like US Patent 11034771 Anti-CD73 anti-PD-L1 bispecific antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
